Aligos reports positive data from Phase IIa MASH treatment trial
In the trial, doses ranging from 0.5mg to 0.9mg of ALG-055009 led to notable median relative reductions in liver fat.
Tectonic Therapeutic reports findings from Phase Ia trial of TX45
Edgewise’s EDG-7500 shows benefit in two obstructive HCM trials
DermaSensor’s skin cancer detection device helps clinicians in published study
Ryvu doses first subject in myelodysplastic syndromes treatment trial
Onward implants second patient with brain chip in spinal cord injury trial
Insilico Medicine reports preliminary data from Phase IIa IPF treatment trial
Keytruda beaten by Summit’s bispecific in NSCLC
Analysis
View More
Themes
View MoreAlio starts trial to expand label for remote monitoring device
The CAVA study is expected to validate the use of SmartPatch technology.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Testosterone could influence men’s immune response to Covid-19
AstraZeneca eyes up transition to eco-friendly inhaler propellant
As mpox spreads, ‘national governments have a moral responsibility to help’
Ultromics’s EchoGo misses primary endpoint in heart disease trial